Pathologic stage i hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8 Clinical Trials

Delta Trials catalogs 6 clinical trials for Pathologic stage i hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8 in its publicly accessible dataset. Within this set, 2 currently recruiting participants and 1 trial have reached completion. This research occurs across 343 participating sites around the world. An additional 3 trials are in other active phases such as not yet recruiting or pending status. Since 2020, 2 trials were withdrawn or terminated prior to completion. All data is sourced directly from ClinicalTrials.gov and updated as trial registrations and statuses evolve over time.